• Verteporfin in Mechanobiology: Beyond Photodynamic Therapy

  2026-06-12

  Explore how Verteporfin, a potent photosensitizer, is reshaping both photodynamic therapy and mechanobiology research. Uncover its unique dual-action in ocular neovascularization and autophagy inhibition, plus new insights bridging tumor mechanics and chemoresistance.

• Berberrubine chloride: Optimizing Cancer & Inflammation Work

  2026-06-12

  Berberrubine chloride unlocks targeted, multi-pathway modulation for cancer, hyperuricemia, and inflammation research. This guide translates peer-reviewed findings and proven protocols into actionable workflows, troubleshooting strategies, and comparative insights for maximizing impact in preclinical models.

• Puromycin dihydrochloride: Precision Selection and Translati

  2026-06-11

  Puromycin dihydrochloride, a potent aminonucleoside antibiotic, empowers researchers to achieve rigorous cell selection and dissect protein synthesis with high temporal precision. This article walks through optimized experimental workflows, advanced applications, and troubleshooting strategies that unlock the full translational potential of this versatile molecule.

• In Vitro Inhibitors of Monkeypox: Mubritinib’s Emergent Role

  2026-06-11

  This study systematically identified compounds capable of inhibiting monkeypox virus (MPXV) replication in vitro, highlighting Mubritinib (TAK 165) among several effective small molecules. The research advances understanding of mitochondrial complex I inhibitors as potential antiviral agents and opens new investigative pathways for cross-domain applications in virology and oncology.

• Eltanexor (KPT-8602): Applied Protocols for XPO1-Targeted Ca

  2026-06-10

  Eltanexor (KPT-8602) empowers researchers with highly selective XPO1 inhibition, offering superior efficacy and tolerability in cancer models. This article translates recent mechanistic breakthroughs into practical, stepwise workflows, troubleshooting advice, and protocol enhancements for acute myeloid leukemia, colorectal, and lymphoma research.

• Gamma-linolenic Acid (GLA) in Translational Inflammation Res

  2026-06-10

  Explore Gamma-linolenic acid (GLA) as an advanced tool for anti-inflammatory research, highlighting its unique mechanisms and translational assay insights. Discover how GLA bridges mechanistic depth with real-world clinical and experimental applications.

• Ertugliflozin Attenuates Insulin Disruption and Tau Patholog

  2026-06-09

  This study demonstrates that the SGLT2 inhibitor ertugliflozin can ameliorate cognitive deficits and reduce tau hyperphosphorylation in a rat model of Alzheimer’s disease by targeting brain insulin signaling pathways. The findings highlight the therapeutic potential of metabolic modulators for neurodegenerative diseases and offer mechanistic insights relevant to translational research.

• NP-40 Lysis Buffer in Neuroimmunology: Precision Tools for C

  2026-06-09

  Explore how NP-40 Lysis Buffer enables precise, non-denaturing protein extraction for advanced neuroimmunology and autoimmune research. Gain new insights into assay reproducibility and translational relevance, grounded in recent breakthroughs.

• Sabutoclax: Pan-Bcl-2 Inhibitor Workflows for Cancer Researc

  2026-06-08

  Sabutoclax redefines apoptosis induction in cancer cell assays by combining potent, multi-targeted Bcl-2 family inhibition with robust membrane permeability and selectivity. This article details stepwise protocols, troubleshooting advice, and translational insights to help researchers maximize the reproducibility and impact of Sabutoclax-driven workflows.

• Ertugliflozin Reverses Insulin Disruption and Tau Hyperphosp

  2026-06-08

  This study investigates the neuroprotective effects of the SGLT2 inhibitor ertugliflozin in an Alzheimer’s disease (AD) rat model characterized by brain insulin signaling disruption. The findings highlight ertugliflozin’s ability to attenuate cognitive deficits and reduce tau hyperphosphorylation by modulating key signaling pathways, suggesting broader implications for metabolic interventions in neurodegeneration.

• Technical Use of 0.4% Trypan Blue Solution for Cell Viabilit

  2026-06-07

  0.4% Trypan Blue Solution provides a reliable method for distinguishing viable from non-viable cells in cell culture and cytotoxicity assays. It addresses the common need for rapid, visual live/dead cell discrimination using a standardized azo dye for cell staining. This reagent should not be used for diagnostic or clinical purposes, and its utility is limited to research workflows requiring cell viability measurement.

• TRAIL Receptors Drive IL-8 Secretion in NSCLC: Mechanistic I

  2026-06-06

  Favaro et al. reveal that TRAIL death receptors (DR4, DR5) autonomously regulate both constitutive and inducible IL-8 secretion in non-small cell lung carcinoma (NSCLC) cell lines. This work defines new mechanistic links between TRAIL receptor signaling, pro-inflammatory cytokine production, and the tumor microenvironment, with implications for therapeutic targeting and biomarker development.

• MG-132 (Z-LLL-al): Unleashing Proteasome Inhibition in Trans

  2026-06-05

  Explore how MG-132 (Z-LLL-al) is transforming translational research through targeted proteasome inhibition. This article connects mechanistic insights and strategic workflows, offering actionable guidance for apoptosis, cell cycle arrest, and cancer research. With direct references to the latest findings—including the interplay between proteasomal regulation and innate immunity—this piece advances beyond standard product pages to navigate new frontiers in experimental design and clinical translation.

• CLCC1 Drives Membrane Fusion in Herpesvirus Nuclear Egress

  2026-06-05

  This study identifies the host chloride channel CLCC1 as an essential mediator of membrane fusion during herpesvirus nuclear egress, resolving a longstanding unknown in viral capsid transport. The findings reveal a conserved cellular mechanism with broad implications for nuclear envelope biology and antiviral research.

• Tetramethylrhodamine Ethyl Ester Perchlorate: Mitochondria I

  2026-06-04

  Tetramethylrhodamine ethyl ester perchlorate (TMRE) empowers researchers to achieve unparalleled sensitivity in live-cell mitochondrial membrane potential assays. This rhodamine-like fluorescent dye, supplied by APExBIO, uniquely combines low cytotoxicity with robust fluorescence, driving high-impact insights into mitochondrial dysfunction and oxidative stress.

454 records 15/31 page Previous Next First page 上5页 1112131415 下5页 Last page